Tango Therapeutics (TNGX) Prepaid Assets (2020 - 2026)
Tango Therapeutics (TNGX) posted quarterly Prepaid Assets of $12.5 million for Q1 2026, up 60.56% year-over-year from $7.8 million in Q1 2025, and up 22.55% quarter-over-quarter from $10.2 million in Q4 2025.
Tango Therapeutics (TNGX) Prepaid Assets (2020 - 2026) Analysis & Trends
Tango Therapeutics' Prepaid Assets history runs 7 years deep, the most recent figure standing at $12.5 million for Q1 2026.
- In Q1 2026, Prepaid Assets rose 60.56% year-over-year to $12.5 million; the TTM figure through Mar 2026 stood at $12.5 million (up 60.56% YoY), while the FY2025 annual figure was $10.2 million, up 20.94% from the prior year.
- Prepaid Assets for Q1 2026 stood at $12.5 million, up from $10.2 million in the prior quarter.
- The five-year high for Prepaid Assets was $17.2 million in Q2 2022, with the low at $5.8 million in Q3 2022.
- The 5-year median for Prepaid Assets is $8.8 million (2023), against an average of $9.2 million.
- The sharpest annual moves came in 2022 and 2023: Prepaid Assets surged 11238.91% in 2022, then plunged 47.35% in 2023.
- Tango Therapeutics' Prepaid Assets stood at $6.6 million in 2022, then soared by 33.86% to $8.8 million in 2023, then dropped by 4.22% to $8.4 million in 2024, then climbed by 20.94% to $10.2 million in 2025, then increased by 22.55% to $12.5 million in 2026.
- Business Quant data shows TNGX's Prepaid Assets at $12.5 million in Q1 2026, $10.2 million in Q4 2025, and $10.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Tango Therapeutics | 4.32 Bn | 3.30 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.68 Mn |
| Mar 31, 2026 | 12.49 Mn |
| Dec 31, 2025 | 10.19 Mn |
| Sep 30, 2025 | 10.54 Mn |
| Jun 30, 2025 | 8.89 Mn |
| Mar 31, 2025 | 7.78 Mn |
| Dec 31, 2024 | 8.43 Mn |
| Sep 30, 2024 | 7.54 Mn |
| Jun 30, 2024 | 6.30 Mn |
| Mar 31, 2024 | 8.44 Mn |
| Dec 31, 2023 | 8.80 Mn |
| Sep 30, 2023 | 10.16 Mn |
| Jun 30, 2023 | 9.04 Mn |
| Mar 31, 2023 | 9.36 Mn |
| Dec 31, 2022 | 6.57 Mn |
| Sep 30, 2022 | 5.81 Mn |
| Jun 30, 2022 | 17.16 Mn |
| Mar 31, 2022 | 8.20 Mn |
| Dec 31, 2021 | 4.52 Mn |
| Sep 30, 2021 | 4.53 Mn |